Therapeutic Botulinum Toxin | Market Insights | Global | 2022
In 2020, the global therapeutic BTX market was negatively impacted by the COVID-19 pandemic. Although some procedures have begun to recover, some procedures are still being deferred. That said, the market will continue to recover going forward as a larger proportion of population is vaccinated. Beyond the impact of the pandemic, the global market for therapeutic BTX will exhibit rapid growth through 2030.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, and Asia Pacific region across an 11-year period
